What Is a Good Model for Enhancer Dysregulation in Neurons?

Check the cell type first. A large share of neurodegeneration and psychiatric risk variants fall in enhancers active in myeloid cells or other glia, not neurons. If the enhancer is glial, a neuronal model will correctly show nothing.

If the enhancer is neuronal:

• • Default: iPSC-derived neurons of the relevant subtype, matured until activity-dependent enhancers are responsive.
• • When non-cell-autonomous effects matter: neuron–glia co-culture.
• • When architecture matters: brain organoids, accepting lower throughput and higher variability.

An enhancer study needs the enhancer to be responsive, not merely present. Practically:

• • Activity-dependent enhancers require stimulation and a maturity state where immediate-early gene induction works.
• • Subtype-specific enhancers require demonstrated subtype identity, not just pan-neuronal markers.
• • Developmental enhancers may be active only transiently — the model's age becomes an experimental variable.

A common failure: measuring at day 21 a phenotype that only appears once network activity matures, or the reverse.

Pair an element-level readout with a functional one; a mark change alone is a mechanism hypothesis.

For a neuronal enhancer variant, the smallest defensible experiment is:

• • Isogenic iPSC-derived neurons, both edit directions, two clones per genotype.
• • Enhancer-level readout: accessibility or H3K27ac at the element under stimulation.
• • Target gene expression at baseline and after stimulation, with a neighbouring gene as control.
• • One functional readout appropriate to the subtype — electrophysiology, imaging, or a secreted analyte.

That package covers element, transcript, and consequence. Anything less is either a mark change without meaning or an expression change without an element.

EDITGENE builds isogenic iPSC-derived neuronal panels with subtype characterization, maturity markers, stimulation protocols validated for enhancer responsiveness, and element-level plus functional readouts.

Tell us the enhancer and the neuronal subtype. Contact EDITGENE to request a project consultation or quote.

Cell-type assignment of an enhancer depends on the reference datasets used; verify in the model rather than assuming from annotation.

iPSC-derived neurons approximate but do not reproduce human circuits; findings require corroboration before circuit-level claims.

• • Nott A, et al. Brain cell type-specific enhancer–promoter interactome maps and disease-risk association. Science. 2019;366:1134–1139.
• • Dolmetsch R, Geschwind DH. The human brain in a dish: the promise of iPSC-derived neurons. Cell. 2011;145:831–834.
• • Corces MR, et al. Single-cell epigenomic analyses implicate candidate causal variants at inherited risk loci. Nature Genetics. 2020;52:1158–1168.